Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
about
Preclinical lupusPreclinical systemic lupus erythematosusPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEWeighing in on autoimmune disease: Big data tip the scale.Pre-rheumatoid arthritis and its prevention.Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.The lung may play a role in the pathogenesis of rheumatoid arthritis.Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibody-positive rheumatoid arthritis: results from the Malaysian Epidemiological Investigation of Rheumatoid Arthritis (MyEIRA).Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis.Autoantibody profiling to follow evolution of lupus syndromesRegional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study.Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritisCan rheumatoid arthritis be prevented?Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.Epigenetics in rheumatoid arthritis: a primer for rheumatologists.Smoking and inflammation: evidence for a synergistic role in chronic disease.Human autoimmune diseases: a comprehensive update.Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.Epigenetics in the pathogenesis of RA.The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritisTargeting mechanisms at sites of complement activation for imaging and therapy.Genetic and environmental risk factors for rheumatoid arthritis.The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis.Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis.Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing.Sjögren syndrome
P2860
Q26863306-ABA020C2-FFE1-489D-B6BC-458FB65C5972Q27000666-7A936E64-3D43-494C-A30D-AB7EB678A2BDQ27003201-8E949F64-8A2C-49EC-898B-CD9E4BA1E28FQ30587275-91025941-A079-4FC6-8908-EB90D5A0EAE3Q33806701-49F4FFF3-A95C-4A64-BCB2-E7D03C97213AQ35533807-3F01CE20-D273-40F0-ABAE-1BFB575E8CD1Q35747705-BA3402D3-8820-4352-B1ED-B45F99DED4D5Q36245865-6DC52AA4-35EA-4BE8-B974-A840EA99B64EQ36633164-10F4A2D5-C134-431D-8D13-FE218AF71B99Q36633359-D4CF3CC2-A092-4979-BC2D-B45C5AA5731AQ37274455-B24BB7A5-E9AE-40C3-9A84-11FFFEF7A82DQ37492376-1D40466F-7E64-45C9-9B0B-54BAB773075FQ37589108-2197708D-AA3E-44EF-9068-18579D706D0AQ38024758-56C5B616-86FA-45D2-9FB2-8F0671A2731BQ38145001-BC200121-FCCA-4D63-A74F-1495A0ACFCE1Q38169801-DB581C17-B7CF-43CB-AE7F-F22883B2C57CQ38554722-E1CED1F7-0E33-4EF3-8D1A-DA02D5C03DE0Q38851096-F57F3431-F0F8-4958-A0B6-E13291A20DEFQ38893197-93EEA763-7B0D-4E71-9B2A-3FB764379BC9Q39190505-74DB23E1-3B32-447D-A417-E4C54714E622Q40369679-A6BB4135-E179-400B-9041-C42C36815CBFQ42375845-2C0BC5F7-68BB-416D-A431-ACC425523418Q42592977-586EBCF5-65C5-4952-BC78-004C17EDADCEQ43194836-CB90A1D1-606E-479C-8842-D57F0DF3C411Q47563245-914F9A3B-A6DA-4662-A2E8-BDA02F2993DFQ50755235-C0C695EA-6E09-41EA-8721-108CA27C5A13Q51092697-5DF10A83-1E93-4481-8AA7-9FB8C821C7C0Q55279741-F98ECB12-DFF6-48E0-94D9-C75BC61158B3Q55970262-038DBA57-D23E-4BE5-93FF-B752303EB41B
P2860
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@en
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@nl
type
label
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@en
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@nl
prefLabel
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@en
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@nl
P356
P1476
Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
@en
P2093
Tom W J Huizinga
P304
P356
10.1136/ARD.2010.142109
P407
P577
2010-12-01T00:00:00Z